|
Market Closed -
Nasdaq
16:00:00 2026-08-27 EDT
|
5-day change | 1st Jan Change | ||
| 8.880 USD | +1.14% |
|
+3.26% | +33.53% |
| 08-05 | Evolus, Inc., Q2 2026 Earnings Call, Aug 05, 2026 | |
| 08-05 | Evolus, Inc. Raises Earnings Guidance for the Full Year 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 580M | - | ||||
| 1,060B | |||||
| 651B | - | - | - | ||
| 465B | |||||
| 365B | |||||
| 300B |
- Stock Market
- Stocks
- EOLS Stock
- Charts Evolus, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
